Status:
COMPLETED
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
Lead Sponsor:
Vyne Therapeutics Inc.
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
Eligibility Criteria
Inclusion
- Male or female age 18 and older who was healthy
- Was of any Fitzpatrick Skin Type or race, providing the skin pigmentation allowed for discernment of erythema
Exclusion
- \-
Key Trial Info
Start Date :
September 8 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2016
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT04052711
Start Date
September 8 2016
End Date
December 19 2016
Last Update
August 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.